Citenamide

Citenamide
Clinical data
Other names	5H-Dibenzo[a,d]cycloheptene-5-carboxamide, Cytenamide, AY-15,613.
Identifiers
	IUPAC name tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide;
CAS Number	10423-37-7;
PubChem CID	25255;
ChemSpider	23588;
UNII	17NZ10DWW0;
KEGG	D03527;
ChEMBL	ChEMBL2104133;
CompTox Dashboard (EPA)	DTXSID00146356 ;
Chemical and physical data
Formula	C16H13NO
Molar mass	235.286 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=CC=C2C(C3=CC=CC=C3C=CC2=C1)C(=O)N;
	InChI InChI=1S/C16H13NO/c17-16(18)15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-10,15H,(H2,17,18); Key:HXQAPLNYYFQSFU-UHFFFAOYSA-N;

Citenamide is a tricyclic chemical agent that is very similar in character to and most closely resembles carbamazepine (Tegretol), which a non-addictive anticonvulsant agent used to treat epileptic seizures, schizophrenia, phantom limb pain and alcoholism. Citenamide contains an amide functional group whereas carbamazepine contains a urea. Citenamide is an old drug and there is little pharmacological data surrounding its use in medicine.^[1]^[2]^[3]^[4]